Hologic, Inc. (NASDAQ: HOLX) on Tuesday, plunged -3.13% from the previous trading day, before settling in for the closing price of $77.54. Within the past 52 weeks, HOLX’s price has moved between $64.02 and $87.88.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 7.03%. The company achieved an average annual earnings per share of 1.96%. With a float of $231.12 million, this company’s outstanding shares have now reached $241.71 million.
Let’s determine the extent of company efficiency that accounts for 6990 employees.
Hologic, Inc. (HOLX) Insider Activity
Observing investor behavior towards Medical Instruments & Supplies industry stocks is more important than anything else. The insider ownership of Hologic, Inc. is 1.54%, while institutional ownership is 98.09%. The most recent insider transaction that took place on Mar 14 ’24, was worth 1,241,296. In this transaction Director of this company sold 16,441 shares at a rate of $75.50, taking the stock ownership to the 48,611 shares. Before that another transaction happened on Mar 08 ’24, when Company’s Director sold 9,039 for $76.40, making the entire transaction worth $690,607. This insider now owns 132,927 shares in total.
Hologic, Inc. (HOLX) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 75.11 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 1.96% per share during the next fiscal year.
Hologic, Inc. (NASDAQ: HOLX) Trading Performance Indicators
Hologic, Inc. (HOLX) is currently performing well based on its current performance indicators. A quick ratio of 3.18 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.44. Likewise, its price to free cash flow for the trailing twelve months is 20.53.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 2.10, a number that is poised to hit 0.98 in the next quarter and is forecasted to reach 4.41 in one year’s time.
Technical Analysis of Hologic, Inc. (HOLX)
Looking closely at Hologic, Inc. (NASDAQ: HOLX), its last 5-days average volume was 1.65 million, which is a drop from its year-to-date volume of 1.82 million. As of the previous 9 days, the stock’s Stochastic %D was 30.20%. Additionally, its Average True Range was 1.31.
During the past 100 days, Hologic, Inc.’s (HOLX) raw stochastic average was set at 64.65%, which indicates a significant increase from 0.24% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 22.05% in the past 14 days, which was higher than the 16.81% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $75.55, while its 200-day Moving Average is $73.46. However, in the short run, Hologic, Inc.’s stock first resistance to watch stands at $77.07. Second resistance stands at $79.02. The third major resistance level sits at $80.01. If the price goes on to break the first support level at $74.13, it is likely to go to the next support level at $73.14. Should the price break the second support level, the third support level stands at $71.19.
Hologic, Inc. (NASDAQ: HOLX) Key Stats
Market capitalization of the company is 17.63 billion based on 234,732K outstanding shares. Right now, sales total 4,030 M and income totals 456,000 K. The company made 1,013 M in profit during its latest quarter, and 246,500 K in sales during its previous quarter.
